Alterola Biotech Inc
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailabil… Read more
Market Cap & Net Worth: Alterola Biotech Inc (ABTI)
Alterola Biotech Inc (PINK:ABTI) has a market capitalization of $2.34 Million ($2.34 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37106 globally and #12070 in its home market, demonstrating a -55.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alterola Biotech Inc's stock price $0.00 by its total outstanding shares 1459502018 (1.46 Billion).
Alterola Biotech Inc Market Cap History: 2015 to 2025
Alterola Biotech Inc's market capitalization history from 2015 to 2025. Data shows change from $4.38 Billion to $2.34 Million (-54.89% CAGR).
Alterola Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alterola Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ABTI by Market Capitalization
Companies near Alterola Biotech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Alterola Biotech Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Alterola Biotech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Alterola Biotech Inc's market cap moved from $4.38 Billion to $ 2.34 Million, with a yearly change of -54.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.34 Million | -68.00% |
| 2024 | $7.30 Million | +38.89% |
| 2023 | $5.25 Million | -92.80% |
| 2022 | $72.98 Million | -65.75% |
| 2021 | $213.09 Million | -54.39% |
| 2020 | $467.19 Million | -69.51% |
| 2019 | $1.53 Billion | -67.69% |
| 2018 | $4.74 Billion | +113.82% |
| 2017 | $2.22 Billion | -49.33% |
| 2016 | $4.38 Billion | 0.00% |
| 2015 | $4.38 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Alterola Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.34 Million USD |
| MoneyControl | $2.34 Million USD |
| MarketWatch | $2.34 Million USD |
| marketcap.company | $2.34 Million USD |
| Reuters | $2.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.